Humacyte makes bioengineered human blood vessels, sold as Symvess, for hospitals and trauma centers. It last closed at $0.45 on Nov 20, down 17.90% on the day. The next earnings report for HUMA is expected around Thu, Mar 18, 2027. For the quarter ended Sep 2026, HUMA reported EPS of -$0.06 on revenue of $1.0M, with revenue up 36.5% from a year ago. Over its last 8 reports the stock moved an average of 16.3% the session after earnings. Over the last 12 months HUMA insiders bought $90K of stock on the open market and sold $82K, according to SEC Form 4 filings.
AI Auto Pilots
Is HUMA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold HUMA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on HUMAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
HUMA · as of the Nov 20 close · updated each morning
Downtrend
The stock is 8% below its 20 day and 9% below its 50 day average. It is 72% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 45). The nearest support is the Pivot S1 at $0.42, and the nearest resistance the swing high (Oct 16) at $0.46.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 13.9%/day
Key levels
$1.5252 week high+237.8%
$0.77200 day average+71.1%
$0.57100 day average+26.7%
$0.50Pivot R1+11.1%
$0.4950 day average+8.9%
$0.4820 day average+6.7%
$0.47Pivot+4.4%
$0.46Swing high (Oct 16)+2.2%
$0.45Last close
$0.42Pivot S1−6.7%
$0.39Swing low (Oct 26)−13.3%
$0.3452 week low−24.4%
Indicators
RSI (14)
44.84
Middle of its range
Neutral
MACD
0.01
Below its signal line
Bearish
Stochastic
45.1
Middle of its range
Neutral
ADX (14)
19.9
No clear trend
Williams %R
-76.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
-19.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−0.6%
Change over 10 sessions
Bearish
ATR (14)
$0.06
Typical daily range, 13.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 32.2%/day
Key levels
$1.5252 week high+237.8%
$0.77200 day average+71.1%
$0.57100 day average+26.7%
$0.50Pivot R1+11.1%
$0.4950 day average+8.9%
$0.4820 day average+6.7%
$0.47Pivot+4.4%
$0.46Swing high (Oct 16)+2.2%
$0.45Last close
$0.42Pivot S1−6.7%
$0.39Swing low (Oct 26)−13.3%
$0.3452 week low−24.4%
Indicators
RSI (14)
38.94
Weak, oversold below 30
Neutral
MACD
-0.12
Above its signal line
Bullish
Stochastic
35.6
Middle of its range
Neutral
ADX (14)
17.6
No clear trend
Williams %R
-73.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
-62.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−21.5%
Change over 10 sessions
Bearish
ATR (14)
$0.14
Typical daily range, 32.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for HUMA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how HUMA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow HUMA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for HUMAHow many large options trades hit HUMA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in HUMA in the last 90 days.
From SEC Form 4 filings by HUMA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HUMA is in one of them and how their past HUMA trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Humacyte
Humacyte is a biotechnology company based in Durham, North Carolina, that makes bioengineered human tissues for surgical repair and replacement. Its main product is an acellular tissue engineered vessel sold under the name Symvess, which is approved in the United States as a vascular conduit for adults with arterial injury to the limbs. The company is developing additional vessels for uses such as dialysis access and peripheral artery disease. Its vessels are shipped to hospitals, trauma centers and outpatient surgical settings.